| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-8049(02)00106-5 |
| P698 | PubMed publication ID | 12091074 |
| P2093 | author name string | S Tanaka | |
| W Yasui | |||
| K Chayama | |||
| K Haruma | |||
| M Yoshihara | |||
| Y Kitadai | |||
| T Amioka | |||
| P2860 | cites work | Vascular endothelial growth factor B, a novel growth factor for endothelial cells | Q24312842 |
| Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) | Q24321792 | ||
| A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
| Hyperplasia of lymphatic vessels in VEGF-C transgenic mice | Q28238886 | ||
| Molecular cloning of a novel vascular endothelial growth factor, VEGF-D | Q28242486 | ||
| VEGFs, receptors and angiogenesis | Q33644265 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis | Q34729610 | ||
| Molecular and biological properties of the vascular endothelial growth factor family of proteins | Q35313427 | ||
| VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer | Q35786920 | ||
| VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. | Q36641154 | ||
| Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues | Q36642309 | ||
| Vascular endothelial growth factor C induces angiogenesis in vivo. | Q36734917 | ||
| Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors | Q37370535 | ||
| Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis | Q42280089 | ||
| Problems in the definition and treatment of early gastric cancer | Q44458805 | ||
| Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. | Q55261166 | ||
| A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases | Q64330833 | ||
| Predictors of lymph node metastasis in early gastric cancer | Q68084004 | ||
| Early gastric carcinoma with special reference to macroscopic classification | Q69120419 | ||
| Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma | Q72303284 | ||
| Metastasizing intramucosal gastric carcinomas. Well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67 | Q72503311 | ||
| Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma | Q73599382 | ||
| Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer | Q73784708 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1413-1419 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa | |
| P478 | volume | 38 |
| Q37724639 | Angiogenesis and lymphangiogenesis of gastric cancer |
| Q36746626 | Angiogenesis in cancer |
| Q58850416 | Angiogenic factors: role in esophageal cancer, a brief review |
| Q34686222 | Anti-angiogenic therapies for advanced esophago-gastric cancer |
| Q34112190 | Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer |
| Q34268727 | Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer |
| Q89312951 | Classification of nodal stations in gastric cancer |
| Q36695475 | Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers |
| Q36735345 | Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer |
| Q35730252 | Crosstalk between angiogenesis and lymphangiogenesis in tumor progression |
| Q37071863 | Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients |
| Q37400581 | Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model |
| Q40379734 | Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells |
| Q36766051 | Expression and significances of contactin-1 in human gastric cancer |
| Q48364437 | Expression of VEGFR3 in glioma endothelium correlates with tumor grade |
| Q40310175 | Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma |
| Q24805206 | Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma |
| Q36502541 | Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. |
| Q81577557 | Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma |
| Q34017710 | Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma |
| Q48125823 | Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas |
| Q37298544 | High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? |
| Q37132729 | Lymph node metastasis of gastric cancer |
| Q44325208 | Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma |
| Q34802847 | Metastasis via Peritumoral Lymphatic Dilation in Oral Squamous Cell Carcinoma |
| Q35219275 | Molecular mechanisms in lymphangiogenesis: model systems and implications in human disease |
| Q27013620 | Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract |
| Q33576258 | No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer |
| Q28067274 | Prediction of lymph node metastasis and sentinel node navigation surgery for patients with early-stage gastric cancer |
| Q44769429 | Prognostic significance of vascular endothelial growth factor D in gastric carcinoma |
| Q43862000 | Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis |
| Q37407354 | Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction |
| Q35062979 | Regulating the angiogenic balance in tissues |
| Q37787865 | Role of lymphatic vessels in tumor immunity: passive conduits or active participants? |
| Q37596178 | Role of the tumor microenvironment in the pathogenesis of gastric carcinoma |
| Q36394925 | Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists |
| Q80232285 | Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance |
| Q36213772 | Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer |
| Q37148199 | Stroma-directed molecular targeted therapy in gastric cancer |
| Q35584958 | Targeting angiogenesis in esophagogastric adenocarcinoma |
| Q58731258 | The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment |
| Q28076945 | The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development |
| Q36589860 | The role of the VEGF-C/VEGFRs axis in tumor progression and therapy |
| Q45802652 | VEGF-C expression is associated with the poor survival in gastric cancer tissue |
| Q58790074 | VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner |
| Q36901201 | VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis |
| Q80565368 | Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma |
| Q54761141 | Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. |
| Q39664069 | Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism |
| Q35187933 | Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. |
Search more.